Extracorporeal Shockwave Therapy vs Mesotherapy in the Treatment of Myofascial Pain Syndrome: a Case-control Study

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Myofascial Pain SyndromeTrigger Point Pain, Myofascial
Interventions
OTHER

Extracorporeal Shockwave Therapy (Group A)

Each patient was evaluated before treatment for trigger points; patients underwent focal ESWT (PulseWave 2 - Mectronic Medicale s.r.l.) with a specific program for muscle contractures and myofascial pain (80-100 mJ with 2250 pulses of 5-10 Hz).

OTHER

Mesotherapy (Group B)

Each patient was evaluated before treatment for trigger points; after disinfection with Chlorhexidine 2% and sterile gauze, Thiocolchicoside fl 4mg/2ml, and a local anesthetic, Mepivacaine fl 10mg/1ml, diluted in 0.9% NaCl saline, for a final volume of 10 ml, were inoculated mesodermally; 6 to 12 microinjections with needle 26G 0.40x4mm, were performed.

Trial Locations (1)

90127

Functional Recovery and Rehabilitation Unit of the A.O.U.P. Paolo Giaccone, Palermo

All Listed Sponsors
lead

University of Palermo

OTHER